Related Experiment Videos
Electrophysiological effects soon after intravenous beta-methyldigoxin
European Journal of Cardiology
|March 1, 1979
Summary
Beta-methyldigoxin, a digitalis derivative, was ineffective in treating paroxysmal reciprocating atrioventricular tachycardia in patients. This study indicates it is not a suitable alternative for managing this cardiac arrhythmia.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Beta-methyldigoxin is a digitalis derivative known for rapid absorption and onset of action.
- Paroxysmal reciprocating atrioventricular tachycardia (recurrent supraventricular tachycardia) is a condition often associated with accessory pathways.
Observation:
- The study evaluated beta-methyldigoxin's efficacy in 6 patients with paroxysmal reciprocating atrioventricular tachycardia or accessory pathways.
- Hemodynamic studies suggested rapid action after intravenous administration.
Findings:
- Beta-methyldigoxin demonstrated no significant effect on induced tachycardias or atrioventricular (AV) conduction during electrophysiological testing.
- One patient exhibited a minor increase in AV node refractoriness post-injection.
Implications:
- Beta-methyldigoxin is not a recommended treatment for the acute management of paroxysmal reciprocating atrioventricular tachycardia.
- Current effective therapeutic agents remain the standard for prompt correction of this arrhythmia.